1
0
0
News
Acepodia Appoints Thorsten Graef, M.D., Ph.D., as ...GlobeNewswire
www.globenewswire.com
AP — ... Thorsten Graef, M.D., Ph.D., as chief medical officer and Michael Brock as chief strategy officer. These key executive hires add to ...
IMBRUVICA® (ibrutinib) Pooled Analysis Suggests Benefit ...AbbVie News Center
news.abbvie.com
AP — "IMBRUVICA continues to provide a beneficial treatment option for patients with relapsed/refractory mantle cell lymphoma," said Thorsten Graef, AP — "IMBRUVICA continues to provide a beneficial treatment option for patients with relapsed/refractory mantle cell lymphoma," said Thorsten Graef, ...
Interessen
Original Article Phase 3 Trial of Ibrutinib plus Rituximab in ...The New England Journal of Medicine
www.nejm.org
... Thorsten Graef, M.D., Ph.D., Christian Buske, M.D., for the iNNOVATE Study Group and the European Consortium for Waldenström's Macroglobulinemia. N Engl J Thorsten Graef, M.D., Ph.D., Christian Buske, M.D., for the iNNOVATE Study Group and the European Consortium for Waldenström's Macroglobulinemia. N Engl J ...
Download Figures (PPT)The Lancet
www.thelancet.com
... Thorsten Graef, MD, Elizabeth Bilotti, MSN, Steven Treon, MD, Prof Christian Buske, MD. The Lancet Oncology. Volume 18 Issue 2 Pages (February 2017) Thorsten Graef, MD, Elizabeth Bilotti, MSN, Steven Treon, MD, Prof Christian Buske, MD. The Lancet Oncology. Volume 18 Issue 2 Pages (February 2017).
a multicentre, randomised, double-blind studyThe Lancet
www.thelancet.com
... Thorsten Graef, MD, Joseph E Eid, MD, Jennifer Houp, PharmD, Linda Sun, PhD, Scott Vuocolo, PhD, Kenneth C Anderson, MD. The Lancet Oncology. Volume 14 Issue Thorsten Graef, MD, Joseph E Eid, MD, Jennifer Houp, PharmD, Linda Sun, PhD, Scott Vuocolo, PhD, Kenneth C Anderson, MD. The Lancet Oncology. Volume 14 Issue ...
Business-Profile
Thorsten Graef at AbbVie - Department of OncologyResearchGate
www.researchgate.net
Thorsten GRAEF, Head of Development | Cited by | of AbbVie, Illinois (ABBVIE) | Read 102 publications | Contact Thorsten GRAEF. Thorsten GRAEF, Head of Development | Cited by | of AbbVie, Illinois (ABBVIE) | Read 102 publications | Contact Thorsten GRAEF.
Bücher
Escalation therapy with bortezomib, dexamethasone and ...Taylor & Francis Online
www.tandfonline.com
von R Fenk · · Zitiert von: 61 — Thorsten Graef Department of Structural Biology, Stanford University, Palo Alto, CA, USA. ,. Akos Czibere Department of Haematology, Oncology and Clinical ... von R Fenk · · Zitiert von: 61 — Thorsten Graef Department of Structural Biology, Stanford University, Palo Alto, CA, USA. ,. Akos Czibere Department of Haematology, Oncology and Clinical ...
Phase 1 trial of ibrutinib and carfilzomib combination ...Taylor & Francis Online
www.tandfonline.com
von A Chari · · Zitiert von: 26 — Yvonne Pak: formal analysis, data curation. Zeena Salman, Thorsten Graef, Elizabeth Bilotti: conceptualization, methodology, project administration. von A Chari · · Zitiert von: 26 — Yvonne Pak: formal analysis, data curation. Zeena Salman, Thorsten Graef, Elizabeth Bilotti: conceptualization, methodology, project administration.
Dokumente zum Namen
ACE1831: A novel allogeneic αCD20-conjugated Vδ2 gamma ...aacrjournals.org
aacrjournals.org
von TS Wu · — ... Thorsten Graef;. Thorsten Graef. 1Acepodia Biotech Inc., San Mateo, CA ... Thorsten Graef, Sai-Wen Tang, Sonny Hsiao. ACE1831: A novel ... von TS Wu · — ... Thorsten Graef;. Thorsten Graef. 1Acepodia Biotech Inc., San Mateo, CA ... Thorsten Graef, Sai-Wen Tang, Sonny Hsiao. ACE1831: A novel ...
Prognostic factors for patients with acute myeloid ...Wiley Online Library
onlinelibrary.wiley.com
von T Graef · · Zitiert von: 8 — ... Thorsten Graef,. Thorsten Graef. Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Duesseldorf, Germany. von T Graef · · Zitiert von: 8 — ... Thorsten Graef,. Thorsten Graef. Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Duesseldorf, Germany.
Abstract - AAI JournalsThe American Association of Immunologists
journals.aai.org
von HG Hilton · · Zitiert von: 97 — Thorsten Graef;. Thorsten Graef. *Department of Structural Biology, Stanford University School of Medicine, Stanford, CA ;. †Department of Microbiology ... von HG Hilton · · Zitiert von: 97 — Thorsten Graef;. Thorsten Graef. *Department of Structural Biology, Stanford University School of Medicine, Stanford, CA ;. †Department of Microbiology ...
Abstract 699: Optimized dosing strategies resulting in ...aacrjournals.org
aacrjournals.org
von A Schuller · · Zitiert von: 1 — ... Thorsten Graef;. Thorsten Graef. 3Merck, Rahway, NJ;. Search for other works by this author on: This Site · PubMed · Google Scholar. Ellie Im;. von A Schuller · · Zitiert von: 1 — ... Thorsten Graef;. Thorsten Graef. 3Merck, Rahway, NJ;. Search for other works by this author on: This Site · PubMed · Google Scholar. Ellie Im;.
Wissenschaftliche Veröffentlichungen
Phase I Trial of Vorinostat Combined With Bortezomib for ...ScienceDirect.com
www.sciencedirect.com
von DM Weber · · Zitiert von: 62 — ... overlay panel. Donna M. Weber 1 , Thorsten Graef 2 , Mohamad Hussein 3 , Ronald M. Sobecks 4 , Gary J. Schiller 5 , Lisa Lupinacci 2 , James S. Hardwick ... von DM Weber · · Zitiert von: 62 — ... overlay panel. Donna M. Weber 1 , Thorsten Graef 2 , Mohamad Hussein 3 , Ronald M. Sobecks 4 , Gary J. Schiller 5 , Lisa Lupinacci 2 , James S. Hardwick ...
Safety and efficacy of abexinostat, a pan-histone ...Archive ouverte HAL
hal.science
von V Ribrag · · Zitiert von: 78 — ... Thorsten Graef (13) , Franck Morschhauser (14). Afficher plus de détails. 1 IGR - Institut Gustave Roussy 2 Dynamo - Dynamique moléculaire de la ... von V Ribrag · · Zitiert von: 78 — ... Thorsten Graef (13) , Franck Morschhauser (14). Afficher plus de détails. 1 IGR - Institut Gustave Roussy 2 Dynamo - Dynamique moléculaire de la ...
Sustained G-CSF plasma levels following administration of ...ScienceDirect.com
www.sciencedirect.com
von R Fenk · · Zitiert von: 38 — , Nadine Hieronimus a , Ulrich Steidl a b , Ingmar Bruns a , Thorsten Graef a , Fabian Zohren a , Leilani Ruf a , Rainer Haas a , Guido Kobbe a. Show more. von R Fenk · · Zitiert von: 38 — , Nadine Hieronimus a , Ulrich Steidl a b , Ingmar Bruns a , Thorsten Graef a , Fabian Zohren a , Leilani Ruf a , Rainer Haas a , Guido Kobbe a. Show more.
Sonstiges
Acepodia Appoints Thorsten Graef, M.D., Ph.D., as Chief ...Maxpro Ventures
www.maxproventures.com
Acepodia. Acepodia Appoints Thorsten Graef, M.D., Ph.D., as Chief Medical Officer and Michael Brock as Chief Strategy Officer. Acepodia. Acepodia Appoints Thorsten Graef, M.D., Ph.D., as Chief Medical Officer and Michael Brock as Chief Strategy Officer.
Thorsten Graef - AbbvieWiza
wiza.co
View Thorsten Graef's email address () and phone number. Thorsten works at Abbvie as Vice President Oncology Early Development. View Thorsten Graef's email address () and phone number. Thorsten works at Abbvie as Vice President Oncology Early Development.
Thorsten Graef — OfficialUSA.com RecordsOfficial USA
www.officialusa.com
Thorsten Graef · Kinman Ct, Saratoga, CA · Single Family, Attached Garage, 3 spaces, 864 sqft garage · Six bedrooms, Three bathrooms · Lot Size Thorsten Graef · Kinman Ct, Saratoga, CA · Single Family, Attached Garage, 3 spaces, 864 sqft garage · Six bedrooms, Three bathrooms · Lot Size
Thorsten Graefcitybiz
www.citybiz.co
Thorsten Graef. LinkedIn Facebook Twitter Email. Thorsten Graef. May 12, COMPANIES THAT TRUST citybiz. Search for:. Thorsten Graef. LinkedIn Facebook Twitter Email. Thorsten Graef. May 12, COMPANIES THAT TRUST citybiz. Search for:.
A multicenter, open-label phase 2a study of ibrutinib with or ...ASCO Publications
ascopubs.org
von JE Cortes · · Zitiert von: 2 — Cortes, Elihu Estey, Anthony Selwyn Stein, Thorsten Graef, Nora Cavazos, Taisei Kinoshita, Ying Luan, and Ahmed TawashiAuthors Info & Affiliations. von JE Cortes · · Zitiert von: 2 — Cortes, Elihu Estey, Anthony Selwyn Stein, Thorsten Graef, Nora Cavazos, Taisei Kinoshita, Ying Luan, and Ahmed TawashiAuthors Info & Affiliations.
AB-101, an allogeneic, non–genetically modified, natural ...ASCO Publications
ascopubs.org
von R Khanal · · Zitiert von: 1 — Saultz, Ayad Hamdan, Anne M. Robinson, Mili Mandal, Aakash Patel, Thorsten Graef, Anita G. Seto, and Umar FarooqAuthors Info & Affiliations. Publication ... von R Khanal · · Zitiert von: 1 — Saultz, Ayad Hamdan, Anne M. Robinson, Mili Mandal, Aakash Patel, Thorsten Graef, Anita G. Seto, and Umar FarooqAuthors Info & Affiliations. Publication ...
Meiotic recombination generates rich diversity in NK cell ...National Institutes of Health (NIH) (.gov)
www.ncbi.nlm.nih.gov
von PJ Norman · · Zitiert von: 122 — Moesta,1 Deepti Sharma,1 Thorsten Graef,1 Karina L. McQueen,1 Lisbeth A. Guethlein,1 Christine V.F. Carrington,2 Dasdayanee Chandanayingyong,3 Yih-Hsin ... von PJ Norman · · Zitiert von: 122 — Moesta,1 Deepti Sharma,1 Thorsten Graef,1 Karina L. McQueen,1 Lisbeth A. Guethlein,1 Christine V.F. Carrington,2 Dasdayanee Chandanayingyong,3 Yih-Hsin ...
NK Cell Therapy/Rituximab Combination Fast Tracked for ...CGTLive®
www.cgtlive.com
AP — ... Thorsten Graef, MD, chief medical officer, Artiva, said in a statement .1 “We are encouraged by the early clinical data we are seeing with AP — ... Thorsten Graef, MD, chief medical officer, Artiva, said in a statement .1 “We are encouraged by the early clinical data we are seeing with ...
SV Hüttenheim siegt zweistelligBayerischer Fussball-Verband
www.bfv.de
AP — Thorsten Graef musste nach nur 20 Minuten vom Platz, für ihn spielte Jonas Köller weiter. Eine Niederlage war nicht nach dem Geschmack von AP — Thorsten Graef musste nach nur 20 Minuten vom Platz, für ihn spielte Jonas Köller weiter. Eine Niederlage war nicht nach dem Geschmack von ...
Treatment of Severe Hemorrhagic Cystitis after Allogeneic ...Transplantation and Cellular Therapy
www.astctjournal.org
von A Czibere · · Zitiert von: 24 — Thorsten Graef. Thorsten Graef. Affiliations. Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine-University, Düsseldorf ... von A Czibere · · Zitiert von: 24 — Thorsten Graef. Thorsten Graef. Affiliations. Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine-University, Düsseldorf ...
Up and Coming | CenterWatch
www.centerwatch.com
AP — Thorsten Graef has been named chief medical officer of biotechnology company Acepodia. Previously, Graef was vice president of oncology and AP — Thorsten Graef has been named chief medical officer of biotechnology company Acepodia. Previously, Graef was vice president of oncology and ...
Use of RNA interference to inhibit integrin subunit alphaV- ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von T Graef · · Zitiert von: 13 — Thorsten Graef , Ulrich Steidl, Wolfgang Nedbal, Ulrich Rohr, Roland Fenk, Rainer Haas, Ralf Kronenwett. Affiliation. 1 Department of Hematology, Oncology ... von T Graef · · Zitiert von: 13 — Thorsten Graef , Ulrich Steidl, Wolfgang Nedbal, Ulrich Rohr, Roland Fenk, Rainer Haas, Ralf Kronenwett. Affiliation. 1 Department of Hematology, Oncology ...
Thorsten GräfJUNO Immobilien
juno.immo
Thorsten Gräf. Noch mehr Einblicke in die Welt der Immobilien finden Sie auf unseren sozialen Netzwerken: @segetis-immo. Zurück zur Übersicht. Wir freuen uns ...
Thorsten Graef | LinkedIn
www.linkedin.com
View Thorsten Graef's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Thorsten Graef discover ...
sortiert nach Relevanz / Datum